drugset / Trial / NCT02016976
Effect of Local Anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) Cream and Reduction in Dose, Pain and Intravenous Analgesic During Permanent Pacemaker Implantation
RandomizedParallel-groupOpen-labelSupportive care
Summary
The investigators believe that the local anesthetic EMLA (Lidocaine 2.5% and Prilocaine 2.5%) cream will lessen pain and reduce the need for anesthesia and analgesia, when implanting a permanent pacemaker.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lidocaine | Other / unclassified | 2.5 % | — |
| Comparator | prilocaine | Small molecule | 2.5 % | — |
| Comparator | Meperidine | Unknown | 25 mg | — |
| Comparator | Midazolam | Small molecule | 2.5 mg | — |
Indications
No indication recorded.